Glycogen synthase kinase-3β mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore
暂无分享,去创建一个
E. Olson | K. Fishbein | S. Sollott | D. Zorov | M. Juhaszova | C. Antos | Suhn Hee Kim | S. Pepe | K. Ytrehus | B. Ziman | Su-yang Wang | Qin Fu
[1] R. Jope,et al. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3‐kinase activation , 2003, Journal of neurochemistry.
[2] Brian O'Rourke,et al. Synchronized Whole Cell Oscillations in Mitochondrial Metabolism Triggered by a Local Release of Reactive Oxygen Species in Cardiac Myocytes* , 2003, Journal of Biological Chemistry.
[3] C. Brenner,et al. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. , 2003, Current medicinal chemistry.
[4] S. Javadov,et al. Ischaemic Preconditioning Inhibits Opening of Mitochondrial Permeability Transition Pores in the Reperfused Rat Heart , 2003, The Journal of physiology.
[5] Steven P Jones,et al. Differential Actions of Cardioprotective Agents on the Mitochondrial Death Pathway , 2003, Circulation research.
[6] Maria Jesus Martin,et al. The SWISS-PROT protein knowledgebase and its supplement TrEMBL in 2003 , 2003, Nucleic Acids Res..
[7] E. Marbán,et al. Antiapoptotic effect of nicorandil mediated by mitochondrial atp-sensitive potassium channels in cultured cardiac myocytes. , 2002, Journal of the American College of Cardiology.
[8] G. Lopaschuk,et al. Leptin Activates Cardiac Fatty Acid Oxidation Independent of Changes in the AMP-activated Protein Kinase-Acetyl-CoA Carboxylase-Malonyl-CoA Axis* , 2002, The Journal of Biological Chemistry.
[9] S. Krajewski,et al. Calpain and Mitochondria in Ischemia/Reperfusion Injury* , 2002, The Journal of Biological Chemistry.
[10] R. Collins,et al. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[11] P. dos Santos,et al. Mechanisms by which opening the mitochondrial ATP- sensitive K(+) channel protects the ischemic heart. , 2002, American journal of physiology. Heart and circulatory physiology.
[12] D. Yellon,et al. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? , 2002, Cardiovascular research.
[13] W. Stanley. Partial fatty acid oxidation inhibitors for stable angina , 2002, Expert opinion on investigational drugs.
[14] E. Murphy,et al. Phosphorylation of Glycogen Synthase Kinase-3&bgr; During Preconditioning Through a Phosphatidylinositol-3-Kinase–Dependent Pathway Is Cardioprotective , 2002, Circulation research.
[15] A. Avogaro,et al. Effects of treatment with sulfonylurea drugs or insulin on ischemia-induced myocardial dysfunction in type 2 diabetes. , 2002, Diabetes.
[16] J. Weiss,et al. Protection of cardiac mitochondria by diazoxide and protein kinase C: Implications for ischemic preconditioning , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[17] Young-Bum Kim,et al. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase , 2002, Nature.
[18] E. Olson,et al. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] E. Olson,et al. Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo. , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[20] A. Coats. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .
[21] R. Kloner,et al. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 1. , 2001, Circulation.
[22] J. Balligand,et al. Endogenous nitric oxide mechanisms mediate the stretch dependence of Ca2+ release in cardiomyocytes , 2001, Nature Cell Biology.
[23] P. Cohen,et al. The renaissance of GSK3 , 2001, Nature Reviews Molecular Cell Biology.
[24] G. Dorn,et al. Opposing cardioprotective actions and parallel hypertrophic effects of δPKC and ɛPKC , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[25] S. Sollott,et al. Glucagon-Like Peptide-1 Increases cAMP but Fails to Augment Contraction in Adult Rat Cardiac Myocytes , 2001, Circulation research.
[26] Laurence H. Pearl,et al. Crystal Structure of Glycogen Synthase Kinase 3β Structural Basis for Phosphate-Primed Substrate Specificity and Autoinhibition , 2001, Cell.
[27] Jianxin Chen,et al. Twisting integrin receptors increases endothelin-1 gene expression in endothelial cells. , 2001, American journal of physiology. Cell physiology.
[28] Y. Ho,et al. Overexpression of Bcl-2 attenuates apoptosis and protects against myocardial I/R injury in transgenic mice. , 2001, American journal of physiology. Heart and circulatory physiology.
[29] A E Vercesi,et al. Mitochondrial permeability transition and oxidative stress , 2001, FEBS letters.
[30] A. Reith,et al. Selective small‐molecule inhibitors of glycogen synthase kinase‐3 activity protect primary neurones from death , 2001, Journal of neurochemistry.
[31] M. Yaffe,et al. A motif-based profile scanning approach for genome-wide prediction of signaling pathways , 2001, Nature Biotechnology.
[32] G. Dorn,et al. Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[33] R. Kloner,et al. Consequences of brief ischemia: stunning, preconditioning, and their clinical implications: part 2. , 2001, Circulation.
[34] E. Lakatta,et al. The β2-Adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through Gi-Dependent coupling to phosphatidylinositol 3'-kinase , 2000 .
[35] S. Korsmeyer,et al. The apoptotic v-cyclin–CDK6 complex phosphorylates and inactivates Bcl-2 , 2000, Nature Cell Biology.
[36] Steven J. Sollott,et al. Reactive Oxygen Species (Ros-Induced) Ros Release , 2000, The Journal of experimental medicine.
[37] J. Downey,et al. Opening of Mitochondrial KATP Channels Triggers the Preconditioned State by Generating Free Radicals , 2000, Circulation research.
[38] A. Hagège,et al. Cardiac functional improvement by a human Bcl‐2 transgene in a mouse model of ischemia/reperfusion injury , 2000, The journal of gene medicine.
[39] G. Gross. The role of mitochondrial KATP channels in cardioprotection , 2000, Basic Research in Cardiology.
[40] J. Woodgett,et al. Requirement for glycogen synthase kinase-3β in cell survival and NF-κB activation , 2000, Nature.
[41] Y. Tsujimoto,et al. BH4 domain of antiapoptotic Bcl-2 family members closes voltage-dependent anion channel and inhibits apoptotic mitochondrial changes and cell death. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[42] E. Lakatta,et al. The beta(2)-adrenergic receptor delivers an antiapoptotic signal to cardiac myocytes through G(i)-dependent coupling to phosphatidylinositol 3'-kinase. , 2000, Circulation research.
[43] J. Woodgett,et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. , 2000, Nature.
[44] Y. Tsujimoto,et al. Bis, a Bcl-2-binding protein that synergizes with Bcl-2 in preventing cell death , 1999, Oncogene.
[45] I. Angin. Sulfonylurea Drugs Increase Early Mortality in Patients with Diabetes Mellitus after Direct Angioplasty for Acute Myocardial Infarction , 1999 .
[46] EduardoMarbán,et al. Modulation of Mitochondrial ATP-Dependent K+ Channels by Protein Kinase C , 1998 .
[47] E. Marbán,et al. Modulation of mitochondrial ATP-dependent K+ channels by protein kinase C. , 1998, Circulation research.
[48] Douglas C. Wallace,et al. Radicals r'aging , 1998, Nature Genetics.
[49] E. Braunwald,et al. Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. , 1998, Circulation.
[50] B. Mignotte,et al. Mitochondria and apoptosis. , 1998, European journal of biochemistry.
[51] M. Smith,et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels. Possible mechanism of cardioprotection. , 1997, Circulation research.
[52] J. Downey,et al. Signal transduction of ischemic preconditioning. , 1997, Cardiovascular research.
[53] James R. Woodgett,et al. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signalling in intact cells , 1996, Current Biology.
[54] P. Abete,et al. Preconditioning does not prevent postischemic dysfunction in aging heart. , 1996, Journal of the American College of Cardiology.
[55] P. Cohen,et al. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B , 1995, Nature.
[56] C. Croce,et al. Inactivation of Bcl-2 by phosphorylation. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[57] D. Mochly‐Rosen. Localization of protein kinases by anchoring proteins: a theme in signal transduction. , 1995, Science.
[58] J. Downey,et al. Preconditioning of isolated rabbit cardiomyocytes: induction by metabolic stress and blockade by the adenosine antagonist SPT and calphostin C, a protein kinase C inhibitor. , 1994, Cardiovascular research.
[59] J. Downey,et al. Adenosine and A1 selective agonists offer minimal protection against ischaemic injury to isolated rat cardiomyocytes. , 1993, Cardiovascular research.
[60] J. Downey,et al. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart. , 1993, Cardiovascular research.
[61] J. Woodgett,et al. Glycogen synthase kinase-3: functions in oncogenesis and development. , 1992, Biochimica et biophysica acta.
[62] T. Higuti,et al. ATP-sensitive K+ channel in the mitochondrial inner membrane , 1991, Nature.
[63] J. Woodgett,et al. Molecular cloning and expression of glycogen synthase kinase‐3/factor A. , 1990, The EMBO journal.
[64] M. Crompton,et al. A heart mitochondrial Ca2(+)-dependent pore of possible relevance to re-perfusion-induced injury. Evidence that ADP facilitates pore interconversion between the closed and open states. , 1990, The Biochemical journal.
[65] A. Halestrap. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism. , 1989, Biochimica et biophysica acta.
[66] R. Jennings,et al. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. , 1986, Circulation.
[67] E. Lakatta,et al. Single adult rabbit and rat cardiac myocytes retain the Ca2+- and species-dependent systolic and diastolic contractile properties of intact muscle , 1986, The Journal of general physiology.
[68] R. Haworth,et al. The Ca2+-induced membrane transition in mitochondria. III. Transitional Ca2+ release. , 1979, Archives of biochemistry and biophysics.
[69] R. Haworth,et al. The Ca2+-induced membrane transition in mitochondria. I. The protective mechanisms. , 1979, Archives of biochemistry and biophysics.
[70] B Chance,et al. Hydroperoxide metabolism in mammalian organs. , 1979, Physiological reviews.
[71] C. Mannella,et al. Small-angle X-ray scattering from mitochondria. , 1977, Biochimica et biophysica acta.